A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's
Annals of Clinical and Translational Neurology · 2025
DOI: 10.1002/acn3.70057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Natalia E Owen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Huntington Disease, tau Proteins, Glial Fibrillary Acidic Protein. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, UK Medical Research Council, Centre Parkinson Plus Grant and Cure Parkinson's Trust.
Abstract (Originalsprache)
There is a pressing need for blood biomarkers that can identify Huntington's disease (HD) gene carriers' proximity to manifest disease. We previously examined serial serum neurofilament light (NfL) concentrations in 21 premanifest HD gene carriers and 14 controls over 14 years, finding that NfL demonstrates high prognostic value and distinct longitudinal dynamics in premanifest/transitional HD. Here, we report the corresponding results for serum glial fibrillary acidic protein and total tau, providing the first longitudinal and head‐to‐head study of these biomarkers in HD. Our findings do not support the utility of these analytes as prognostic biomarkers in premanifest and transitional HD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK.
- Department of Clinical Neurosciences, Cambridge Centre for Frontotemporal Dementia and Related Disorders, University of Cambridge, Cambridge, UK.
- UK Dementia Research Institute at University of Cambridge, Cambridge, UK.
- Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.
- Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
ORCID-Profile: Natalia E Owen, Maura Malpetti
Förderung
- Wellcome Trust
- UK Medical Research Council
- Centre Parkinson Plus Grant and Cure Parkinson's Trust
- NIHR Cambridge Biomedical Research Centre
- UKRI Medical Research Council
- Alzheimer's Research UK
- Association of British Neurologists/Guarantors of Brain Clinical Research Fellowship
- Alzheimer’s Research UK
Zitieren
APA
Owen, N. E., Voysey, Z. J., Holbrook, J. A., Malpetti, M., Le Draoulec, C., Spindler, L. R. B., Goodman, A. O. G., Lazar, A. S., & Barker, R. A. (2025). A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70057
Vancouver
Owen NE, Voysey ZJ, Holbrook JA, Malpetti M, Le Draoulec C, Spindler LRB, et al. A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70057
BibTeX
@article{Owen2025,
author = {Owen, Natalia E and Voysey, Zanna J and Holbrook, Jonathan A and Malpetti, Maura and Le Draoulec, Clara and Spindler, Lennart R B and Goodman, Anna O G and Lazar, Alpar S and Barker, Roger A},
title = {A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
doi = {10.1002/acn3.70057}
}
EUVIMED